Mitochondrial-derived 16-amino-acid peptide (MRWQEMGYIFYPRKLR) encoded within the mtDNA 12S rRNA. Lyophilized peptide for in vitro AMPK and metabolic pathway research only.
Every batch of MOTS-c is sent to an accredited independent laboratory before it ships. Here is exactly what we screen for - and the certificate that proves it.
Mitochondrial-derived peptide signaling characterized across AMPK, metabolic, and nuclear translocation research models
In the Lee et al. (2015) discovery study, MOTS-c administration in murine and cell models phosphorylates and activates AMP-activated protein kinase (AMPK), the master regulator of cellular energy homeostasis. Activation occurs downstream of altered AMP:ATP ratio and ZMP accumulation.
Lee et al. demonstrated MOTS-c targets the folate cycle, inhibiting methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) and de novo purine biosynthesis. This causes accumulation of AICAR (ZMP), an endogenous AMPK activator, linking mitochondrial signaling to one-carbon metabolism.
Kim et al. (2018) showed that under metabolic stress (glucose restriction, oxidative stress), MOTS-c translocates from mitochondria to the nucleus where it regulates adaptive nuclear gene expression, including antioxidant response element (ARE) and NFE2L2/Nrf2 target genes.
Key findings from foundational MOTS-c publications (preclinical and cell models)
Primary areas of MOTS-c preclinical investigation
MOTS-c is a foundational tool for studying mitochondrial-derived peptides (MDPs) and retrograde mitochondrial-to-nucleus signaling. Used to probe how short ORFs within the mitochondrial genome regulate whole-cell physiology.
Lee et al. 2015 ↗Used as a probe for AMPK activation distinct from AICAR or metformin. Engages the folate cycle and ZMP accumulation upstream of AMPKα phosphorylation, providing a mitochondrial-encoded entry point to the AMPK signaling axis.
Lee et al. 2015 ↗Reynolds et al. (2021) reported MOTS-c administration improved physical performance and skeletal muscle function in aged mice. Investigated in preclinical models of age-related metabolic and musculoskeletal decline.
Reynolds et al. 2021 ↗Cobb et al. (2016) characterized circulating MOTS-c levels and metabolic correlates in human cohorts. Used as a research tool for glucose homeostasis, insulin signaling, and obesity-related metabolic dysfunction in cellular models.
Cobb et al. 2016 ↗Technical specifications and analytical profile
Common questions about MOTS-c research parameters
Peer-reviewed publications and preclinical studies

$40 value — free with any order over $99
You're in! Use this code at checkout:
Add a GHK-Cu vial and apply the code on orders over $99.
Limit 1 per customer
For laboratory research purposes only. Not for human consumption, medical, veterinary, household, or any other use.